In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $134.94 in the prior trading day, Krystal Biotech Inc (NASDAQ: KRYS) closed at $137.35, up 1.79%. In other words, the price has increased by $1.79 from its previous closing price. On the day, 0.63 million shares were traded. KRYS stock price reached its highest trading level at $137.7 during the session, while it also had its lowest trading level at $131.2387.
Ratios:
Our goal is to gain a better understanding of KRYS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.40. For the most recent quarter (mrq), Quick Ratio is recorded 9.33 and its Current Ratio is at 9.68. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 05, 2025, initiated with a Buy rating and assigned the stock a target price of $245.
On August 06, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $195 to $204.
On November 20, 2023, Goldman started tracking the stock assigning a Buy rating and target price of $160.Goldman initiated its Buy rating on November 20, 2023, with a $160 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 14 ’25 when Krishnan Suma sold 13,435 shares for $150.30 per share. The transaction valued at 2,019,225 led to the insider holds 1,443,276 shares of the business.
Krishnan Suma sold 13,400 shares of KRYS for $2,014,015 on Jul 14 ’25. The President, R&D now owns 1,512,529 shares after completing the transaction at $150.30 per share. On Jul 15 ’25, another insider, Krishnan Suma, who serves as the President, R&D of the company, sold 3,084 shares for $151.01 each. As a result, the insider received 465,700 and left with 1,509,445 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KRYS now has a Market Capitalization of 3975321344 and an Enterprise Value of 3300818432. As of this moment, Krystal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.94, and their Forward P/E ratio for the next fiscal year is 17.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.05 while its Price-to-Book (P/B) ratio in mrq is 3.82. Its current Enterprise Value per Revenue stands at 9.189 whereas that against EBITDA is 21.467.
Stock Price History:
The Beta on a monthly basis for KRYS is 0.67, which has changed by -0.21379507 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, KRYS has reached a high of $207.84, while it has fallen to a 52-week low of $122.80. The 50-Day Moving Average of the stock is -2.42%, while the 200-Day Moving Average is calculated to be -14.95%.
Shares Statistics:
The stock has traded on average 401.61K shares per day over the past 3-months and 541640 shares per day over the last 10 days, according to various share statistics. A total of 28.93M shares are outstanding, with a floating share count of 24.83M. Insiders hold about 14.09% of the company’s shares, while institutions hold 93.27% stake in the company. Shares short for KRYS as of 1752537600 were 3142589 with a Short Ratio of 7.82, compared to 1749772800 on 3033623. Therefore, it implies a Short% of Shares Outstanding of 3142589 and a Short% of Float of 18.240000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
